Hey guy's and gal's pulled this off the other site,

New Post Public Reply Private Reply Replies (1) Message Board
Jaxdawson
Hey guy's and gal's pulled this off the other site, compliments of givemeshelter.
Let me know if you think it's legit?

gimmeshelter Tuesday, 04/22/14 11:29:17 PM
Re: None
Post # of 163171
Response from Lakeshore on zoning and permits:

I wrote Mr. Steve Salmons, director of community and development services in hopes of clearing up these issues of debate on the msg. board. Here are the emails we shared, which clears up very little in my view:



Steve Salmons (ssalmons@lakeshore.ca)



ssalmons@lakeshore.ca
Steve Salmons
Director of Community & Development Services



Town of Lakeshore
T 519-728-5004 x292
ssalmons@lakeshore.ca




To: Steve Salmons

mailto:ssalmons@lakeshore.ca

Hello Mr. Salmons,

I am writing to you in hopes you can clear up a few issues regarding CEN Biotech and their current project to build a medical marihuana facility located at North Rear and Manning Roads in Lakeshore.

I am an investor in CEN Biotech and have been trying to follow the process, but as you likely know, there are many conflicting reports regarding zoning issues and building permits needed to comply with municipal and provincial requirements to proceed with their application to Health Canada for licensing.

I'm guessing you've probably received more than a few inquiries into this matter and if you don't have time to answer my questions, I understand. If you can reply, let me say thanks in advance for taking the time.

To begin with, I read the most recent council meeting minutes from the April 8 session where you stated that you had advised the proponent (CEO Bill Chaaban, I assume) that "rezoning and a site plan approval will be required to operate a facility beyond what is allowed in the current agricultural (with value added) zoning that currently exists."

I understand the project's production and need for employees will exceed the limits imposed by the current zoning. I read through the HC guidelines and the MMPR regulations and could not find any requirement that the production sites be zoned as industrial, yet in a recent written statement issued by Adam Szymczak, senior planner for the planning and economic development committee of neighboring city Windsor, also of Essex County, states that, "medical marihuana facilities must be zoned industrial to comply."

Does this stipulation also apply to Lakeshore or is that just a requirement of Windsor and not the county, Health Canada or the MMPR by-laws?

What does CEN Biotech need to do to be in compliance with Lakeshore city codes and zoning laws before they can begin production? (Assuming the licence from HC is forthcoming.)

Will the property need to be rezoned or can amendments be made to accommodate their production facility?

Has the proponent begun addressing this issue with your agency and/or the city council to effect the necessary change?

Assuming CEN Biotech is working diligently to comply, what kind of time frame are we looking at until an agreement can be reached so they can proceed with licensing and production?

Conjecture abounds that this process is either,
a). a simple process that can be remedied in quick fashion, or
b). a complicated process that will not be quickly remedied, or
c). a deal-breaker because of residential zoning with dwellings too close to the proposed production facility to allow for any kind of zoning approval.

What is your view on what it will take for the proponent to become compliant and ready to proceed to the next step?

I've reviewed the city's online guide for "Buildings and Permits" which states that permits are required for the following building projects, which I'm assuming apply to the construction of this site:

* new and replacement water lines
* construction of a new building
* any additions to an existing building
* structural alterations
* renovate, repair or add to a building
* change a building's use
* install or change load-bearing walls
* make new openings or change the size of doors and windows
* excavate a basement or construct a foundation
* install plumbing
* accessory structure larger than 108 square feet
* a deck more than 24' above ground
* new basement entrance

Are the proper permits for these projects in place?

If not, is the proponent working to comply or will they be addressed at the April 22 council meeting?

Is the proponent in danger of facing a work stoppage due to a lack of building permits acquired or any other issues such as permits for installation of gas, plumbing or electrical installation?

And finally, are there any other requirements that the proponent has not met that need to be complied with before gaining approval from the city to proceed and be ready for production?

I will be eagerly awaiting the release of minutes from Tuesday's council meeting to learn more on the progress of the project.

And thanks again for your time in reading and answering my letter.

Michael S.




© Steve Salmons (ssalmons@lakeshore.ca)

Add to contacts

4:00 PM





To: 'Michael S.'







ssalmons@lakeshore.ca

Michael,

I will briefly answer some of your questions, as many of your questions are speculative in nature, or without context.



Licensing is between Health Canada and the proponent, the Town has no involvement. The federal program does require any proponent to comply with all federal, provincial and municipal requirements. Zoning would be a typical requirement.



The Town does view the production of marihuana as an agricultural crop. It is the extent of processing that will determine if any further zoning is required by a proponent. Zoning requests are routine, and relatively straight forward, subject to the approval of Council.



We have been notified by CEN Biotech (as is required in the Act) of their intent to produce medical marihuana at a specific site in Lakeshore. CEN Biotech has not advised Lakeshore that they are seeking or require any zoning accommodations at this time.



You should contact the company for further information.

JAX

Creative Edge Nutrition Inc. (FITX) Stock Research Links

FITX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 3

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Your Rights as a Humacyte, Inc. Investor

Updated Category News Views 110

Understanding Your Rights as a Humacyte, Inc. Investor Humacyte, Inc. (NASDAQ: HUMA) has recently captured the attention of investors due to certain legal developments affecting its share value. If you are a shareholder who purchased shares during the specific class period of May 10, 2024, to October 17, 2024, you may want to take active steps to protect your investment...

Continue Reading
Jim Chanos Raises Concerns About Oracle's Accounting Issues

Updated Category News Views 552

Chanos Questions Oracle's Accounting Practices Notable short-seller Jim Chanos has recently highlighted some serious concerns regarding Oracle Corp's accounting integrity. He has voiced skepticism about the company's massive project backlog, especially a significant $300 billion deal partnered with OpenAI, emphasizing that its operational realization is years away and...

Continue Reading
Cyrus Biotechnology Advances Novel IgG Therapy with No Antibodies

Updated Category News Views 171

Promising Developments by Cyrus Biotechnology Cyrus Biotechnology, Inc. has unveiled groundbreaking data showcasing the effectiveness of its engineered IgG-degrading enzyme, CYR241, in a unique rabbit redosing model. This enzyme demonstrates significant therapeutic activity without the formation of anti-drug antibodies (ADAs) upon repeated administration. Understanding...

Continue Reading
GreenPower Motor Company: Strengthening Its Financial Future

Updated Category News Views 241

GreenPower Motor Company Secures New Term Loan Funding GreenPower Motor Company Inc. (NASDAQ: GP), an innovator in the production and distribution of all-electric medium and heavy-duty vehicles, recently completed the closing of the fifth tranche of its secured term loan offering. This strategic move aims to bolster its operational capabilities, particularly in the cargo,...

Continue Reading
Unlocking the Future: Insights into the Cloud Industry 2025

Updated Category News Views 226

The Promising Future of the Global Cloud Industry The global cloud industry is on a fast track to remarkable growth. Recent research indicates that the market is poised to expand from approximately USD 1,091.4 billion in one year to an impressive USD 1,256.8 billion by 2025. This represents a noteworthy year-over-year increase of about 15.1%. With such staggering figures,...

Continue Reading